title: Metastatic melanoma: how research can modify the course of a disease.
authors.affiliation: Department of Integrated Oncological Therapies, IRCCS AOU San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy.
authors.forename: Paola
authors.initials: P
authors.lastname: Queirolo
authors.affiliation: Department of Integrated Oncological Therapies, IRCCS AOU San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy. patologia.molecolare.integrata@gmail.com.
authors.forename: Ulrich
authors.initials: U
authors.lastname: Pfeffer
mesh_terms: D000911:Antibodies, Monoclonal / Q000276:immunology / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use; D006801:Humans; D007167:Immunotherapy; D008545:Melanoma / Q000276:immunology / Q000473:pathology / Q000652:urine*; D009362:Neoplasm Metastasis; D061026:Programmed Cell Death 1 Receptor / Q000276:immunology / Q000627:therapeutic use*
chemical_list: D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D061026:Programmed Cell Death 1 Receptor
keywords: Immune checkpoint; Immunology; Melanoma; Targeted therapy